| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 35,000 | 289.10 k | 35,000 |
| 14 Jun 24 | PRLD Prelude Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 3.9 | 23,500 | 91.65 k | 23,500 |
| 12 Jun 24 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 7.9 | 25,600 | 202.24 k | 25,600 |
